SS-31 (Elamipretide)

SS-31 (Elamipretide, also known as Bendavia or MTP-131) is a synthetic cell-permeable tetrapeptide that selectively targets the inner mitochondrial membrane. This unique mitochondria-targeting peptide binds to cardiolipin, a phospholipid essential for electron transport chain function and mitochondrial membrane integrity. SS-31 is utilized in laboratory research to study mitochondrial function, bioenergetics, and oxidative stress pathways. All discussion herein is limited to experimental research contexts and does not imply applied, therapeutic, or physiological use.

SS-31 is employed in laboratory research to study mitochondrial function and bioenergetics. Common experimental applications include mitochondrial respiration assays, ROS production measurements, and ATP synthesis studies in isolated mitochondria and intact cells. Research protocols utilize SS-31 to investigate the role of cardiolipin in electron transport chain function, the relationship between mitochondrial membrane integrity and bioenergetics, and strategies for protecting mitochondria under oxidative stress conditions.

Mechanistically, SS-31 concentrates in the inner mitochondrial membrane where it binds to cardiolipin, a negatively charged phospholipid essential for electron transport chain (ETC) complex assembly and function. This binding stabilizes the cytochrome c-cardiolipin interaction, optimizing electron transfer and reducing premature electron leak. By stabilizing the ETC, SS-31 reduces the production of superoxide and other reactive oxygen species at Complexes I and III. Additionally, it prevents cardiolipin peroxidation, which would otherwise disrupt cristae architecture and impair ATP synthesis capacity.

Preclinical investigations of SS-31 include in-vitro mitochondrial studies and in-vivo animal models evaluating mitochondrial function, oxidative damage, and tissue protection. Reported findings include reduced ROS production, improved ATP synthesis, and protection against ischemia-reperfusion injury. Animal studies explore effects in models of cardiac ischemia, skeletal muscle dysfunction, and neurodegenerative conditions, demonstrating broad applications for mitochondrial-targeted interventions. All findings are interpreted strictly within the context of laboratory research models.